Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says Ind Application Of Nvk-002 Approved By CDE Of NMPA Of China

Sept 27 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * IND APPLICATION OF NVK-002 FOR PHASE III CLINICAL TRIAL IN
CHINA
APPROVED BY  CENTER FOR DRUG EVALUATION OF NMPA OF CHINA

Further company coverage:  6622.HK 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news